FOLH1 and Familial prostate cancer: Since the expression of PSMA in the prostate is nearly 100-fold higher than in other tissues and prostate cancer exhibits a tenfold higher expression than the healthy prostate, PSMA has become a conspicuous target for nuclear medicine diagnostics and therapy very recently.